title: Efavirenz dose reduction in HIV-infected patients: a long-term follow-up.
authors.affiliation: aUnità Semplice organizzativa 'Diagnosi e Terapia dell'Infezione da HIV' bInfectious Diseases Unit, G.B. Rossi University Hospital, Verona, Italy cDepartment of Internal Medicine, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Lanzafame
authors.forename: Emanuela
authors.initials: E
authors.lastname: Lattuada
authors.forename: Giulia
authors.initials: G
authors.lastname: Cucchetto
authors.forename: Ercole
authors.initials: E
authors.lastname: Concia
authors.forename: Sandro
authors.initials: S
authors.lastname: Vento
mesh_terms: D000328:Adult; D000368:Aged; D000480:Alkynes; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D048588:Benzoxazines / Q000008:administration & dosage*; D018791:CD4 Lymphocyte Count; D003521:Cyclopropanes; D016903:Drug Monitoring; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D012367:RNA, Viral; C098320:efavirenz